2022
DOI: 10.1016/j.gene.2022.146251
|View full text |Cite
|
Sign up to set email alerts
|

Zinc finger C3H1-type containing serves as a novel prognostic biomarker in human pan-cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…Considering multiple aspects of Zn finger protein signaling domains, they carry the potential to be developed as prognostic markers as well as therapeutic targets in prostate cancer [ 54 , 130 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering multiple aspects of Zn finger protein signaling domains, they carry the potential to be developed as prognostic markers as well as therapeutic targets in prostate cancer [ 54 , 130 ].…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, at the time of prostate cancer diagnoses, men with type II diabetes or pre-diabetes may require additional clinical support to adequately control blood sugar levels, to suppress diabetes-associated Zn urinary excretion which may otherwise further assist in prostate cancer progression. Meanwhile, it is considered that aspects of ZF protein signaling domains, may carry the potential to be developed as prognostic markers as well as therapeutic targets in prostate cancer [ 54 , 130 ].…”
Section: Discussion and Commentarymentioning
confidence: 99%
“…Consequently, a wealth of sequencing and clinical data for different types of cancer is now available (5). By using public databases such as The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO), bioinformatics can be used to perform pan-cancer analysis at the DNA, RNA, protein and epigenetic level to reveal the roles of genes in different cancers (6)(7)(8)(9).…”
Section: Introductionmentioning
confidence: 99%